Results 1 to 10 of about 918,306 (202)
Renal sympathetic denervation for resistant hypertension: where do we stand after more than a decade [PDF]
Brazilian Journal of Nephrology, 2020 Despite the current availability of safe and efficient drugs for treating hypertension, a substantial number of patients are drug-resistant hypertensives.
Marco Antônio Peliky Fontes +3 more
doaj +4 more sources
Exploring the relationship between ventricular fibrillation recurrence after defibrillation in myocardial infarction and the effectiveness of renal sympathetic denervation therapy [PDF]
BMC Cardiovascular DisordersObjective This study aimed to explore the association between electrophysiological markers of early recurrence after defibrillation in post-myocardial infarction ventricular fibrillation and the therapeutic effects of sympathetic renal denervation, as ...
Caixia Lin, Zhengyu Feng, Xiaowei Qiu
doaj +2 more sources
Reconsidering Renal Sympathetic Denervation for Heart Failureâ [PDF]
JACC: Basic to Translational Science, 2017 [Figure: see text]
W.H. Wilson Tang, MD, Mark E. Dunlap, MD
doaj +4 more sources
Renal sympathetic denervation: A promising therapy for resistant hypertension
Heart India, 2014 Despite rapid strides in pharmacotherapy for hypertension over last few decades, resistant hypertension continues to be prevalent. Activation of the sympathetic nervous system is an important etiological factor in the pathogenesis of hypertension and ...
Deepak Ameta +2 more
doaj +2 more sources
Exploring the mechanisms connecting the sympathetic nervous system and type 2 diabetes: Focus on renal denervation [PDF]
Journal of Research in Medical SciencesThe interplay between sympathetic nervous system activation and metabolic disorders, particularly type 2 diabetes mellitus (T2DM) and hypertension, has been increasingly recognized as a critical factor in cardiovascular morbidity and mortality.
Ahmadali Jalalinezhad +3 more
doaj +2 more sources
REC: Interventional Cardiology (English Ed.), 2022 Hypertension is the most prevalent cardiovascular risk factor. Despite pharmacological treatment, a high percentage of patients do not achieve an adequate blood pressure control.
Oriol Rodríguez-Leor +13 more
doaj +1 more source
Antioxidants, 2022 Oxidative stress and sustained sympathetic over-activity contribute to the pathogenesis of hypertension. Catheter-based renal denervation has been used as a strategy for treatment of resistant hypertension, which interrupts both afferent and efferent ...
Lu-Lu Wu +10 more
doaj +1 more source
Sympathetic Denervation Ameliorates Renal Fibrosis via Inhibition of Cellular Senescence
Frontiers in Immunology, 2022 ObjectiveContinuous overactivation of the renal sympathetic nerve is considered to be an important cause of renal fibrosis. Accumulated senescent cells in the damaged kidney have metabolic activities and secrete amounts of proinflammatory factors as part
Qian Li +7 more
doaj +1 more source
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021 Background Recent trial results support the efficacy of renal sympathetic denervation in lowering blood pressure (BP). While BP reduction in general is associated with a clinically meaningful reduction in cardiovascular events and mortality, such a ...
Karl Fengler +11 more
doaj +1 more source
Device-based approaches for renal nerve ablation for hypertension and beyond
Frontiers in Physiology, 2015 Animal and human studies have demonstrated that chronic activation of renal sympathetic nerves is critical in the pathogenesis and perpetuation of treatment-resistant hypertension.
Alicia Ann Thorp +2 more
doaj +1 more source